CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells (original) (raw)

• Draper, J.S. et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22, 53–54 (2004).
  Article CAS Google Scholar
• Cowan, C.A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353–1356 (2004).
  Article CAS Google Scholar
• Zeng, X. et al. BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation. Restor. Neurol. Neurosci. 22, 421–428 (2004).
  CAS PubMed Google Scholar
• Maitra, A. et al. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37, 1099–1103 (2005).
  Article CAS Google Scholar
• Durkop, H. et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68, 421–427 (1992).
  Article CAS Google Scholar
• Horie, R. & Watanabe, T. CD30: expression and function in health and disease. Semin. Immunol. 10, 457–470 (1998).
  Article CAS Google Scholar
• Durkop, H. et al. Expression of the CD30 antigen in non-lymphoid tissues and cells. J. Pathol. 190, 613–618 (2000).
  Article CAS Google Scholar
• Pera, M.F., Bennett, W. & Cerretti, D.P. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors. Lab. Invest. 76, 497–504 (1997).
  CAS PubMed Google Scholar
• Horie, R. et al. A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages. Blood 88, 2422–2432 (1996).
  CAS PubMed Google Scholar
• Croager, E.J., Gout, A.M. & Abraham, L.J. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am. J. Pathol. 156, 1723–1731 (2000).
  Article CAS Google Scholar
• Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000).
  Article CAS Google Scholar
• Xu, C. et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971–974 (2001).
  Article CAS Google Scholar
• Oosterhuis, J.W. & Looijenga, L.H. Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer 5, 210–222 (2005).
  Article CAS Google Scholar
• Henegariu, O. et al. Characterization of gains, losses, and regional amplification in testicular germ cell tumor cell lines by comparative genomic hybridization. Cancer Genet. Cytogenet. 148, 14–20 (2004).
  Article CAS Google Scholar
• Pallesen, G. & Hamilton-Dutoit, S.J. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am. J. Pathol. 133, 446–450 (1988).
  CAS PubMed PubMed Central Google Scholar
• Pera, M.F., Bennett, W. & Cerretti, D.P. CD30 and its ligand: possible role in regulation of teratoma stem cells. APMIS 106, 169–173 (1998).
  Article CAS Google Scholar
• Amakawa, R. et al. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84, 551–562 (1996).
  Article CAS Google Scholar
• Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A. & Bongso, A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399–404 (2000).
  Article CAS Google Scholar
• Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
  Article CAS Google Scholar
• Buzzard, J.J., Gough, N.M., Crook, J.M. & Colman, A. Karyotype of human ES cells during extended culture. Nat. Biotechnol. 22, 381–382, author reply, 382 (2004).
  Article CAS Google Scholar
• Pera, M.F., Cooper, S., Mills, J. & Parrington, J.M. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation 42, 10–23 (1989).
  Article CAS Google Scholar
• Kadin, M.E. Regulation of CD30 antigen expression and its potential significance for human disease. Am. J. Pathol. 156, 1479–1484 (2000).
  Article CAS Google Scholar
• Enver, T. et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum. Mol. Genet. 14, 3129–3140 (2005).
  Article CAS Google Scholar
• Andrews, P.W. et al. The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nat. Biotechnol. 23, 795–797 (2005).
  Article CAS Google Scholar
• Doronina, S.O. et al. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat. Biotechnol. 21, 778–784 (2003).
  Article CAS Google Scholar
• Pera, M.F., Blasco Lafita, M.J. & Mills, J. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. Int. J. Cancer 40, 334–343 (1987).
  Article CAS Google Scholar
• Herszfeld, D. & Pera, M.F. Differentiation of human pluripotent teratocarcinoma cells induced by bone morphogenetic protein-2. Reprod. Fertil. Dev. 10, 551–555 (1998).
  Article Google Scholar
• Pera, M.F. et al. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell Sci. 117, 1269–1280 (2004).
  Article CAS Google Scholar
• Roach, S., Schmid, W. & Pera, M.F. Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3α in models of early endodermal cell differentiation. Exp. Cell Res. 215, 189–198 (1994).
  Article CAS Google Scholar
• Pera, M.F., Filipczyk, A.A., Hawes, S.M. & Laslett, A.L. Isolation, characterization, and differentiation of human embryonic stem cells. Methods Enzymol. 365, 429–446 (2003).
  Article CAS Google Scholar